Johnson & Johnson’s Talcum Powder trial Update
Johnson & Johnson Loses Fifth Talcum Powder Trial
June 8, 2017
A St. Louis courtroom was the setting for Johnson & Johnson’s fifth major loss in its ongoing series of trials concerning its talcum powder products. The pharmaceutical giant was found guilty of negligence, and has been ordered to pay a Virginia woman more than $110 million in compensatory and punitive damages.
The jury found that Lois Slemp, 62, had developed ovarian cancer at least in part because of her prolonged use of talcum powder products that Johnson & Johnson had marketed and promoted as safe. Slemp is currently undergoing her second round of chemotherapy treatment for her cancer.
The loss is the fifth in six talcum-powder cases for Johnson & Johnson. In previous decisions, the company has been ordered to pay multiple awards in the tens of millions of dollars.
This most recent trial stands out for the two-pronged nature of the plaintiff’s cancer. Slemp’s reproductive organs were found to contain not only talc particles, but asbestos, another substance that can cause cancer. Some talc products are known to be contaminated with this dangerous material.
Big Pharma is vulnerable like they’ve never been before. If you have ovarian cancer, and you think it might be linked to the use of talc-based hygiene products, contact TheLawFirm.com. We can help.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!